TOSI, GIAN MARCO
 Distribuzione geografica
Continente #
NA - Nord America 15.238
EU - Europa 12.993
AS - Asia 7.346
SA - Sud America 1.340
AF - Africa 437
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 37.396
Nazione #
US - Stati Uniti d'America 14.993
GB - Regno Unito 2.861
RU - Federazione Russa 2.673
IT - Italia 2.484
CN - Cina 2.289
SG - Singapore 2.256
IE - Irlanda 1.389
BR - Brasile 1.083
VN - Vietnam 857
SE - Svezia 733
FR - Francia 676
DE - Germania 662
UA - Ucraina 633
HK - Hong Kong 560
KR - Corea 372
FI - Finlandia 300
IN - India 234
BD - Bangladesh 198
ZA - Sudafrica 192
TR - Turchia 146
CA - Canada 125
NL - Olanda 107
ES - Italia 90
AR - Argentina 71
IQ - Iraq 68
MX - Messico 66
BE - Belgio 63
JP - Giappone 58
PK - Pakistan 57
NG - Nigeria 54
PL - Polonia 52
CH - Svizzera 51
CI - Costa d'Avorio 46
AT - Austria 39
VE - Venezuela 39
EC - Ecuador 37
KE - Kenya 36
CZ - Repubblica Ceca 35
ID - Indonesia 33
CO - Colombia 29
LT - Lituania 29
SA - Arabia Saudita 28
AU - Australia 27
CL - Cile 27
EG - Egitto 23
MA - Marocco 23
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 21
BY - Bielorussia 21
DZ - Algeria 18
IR - Iran 18
JO - Giordania 18
PY - Paraguay 15
BO - Bolivia 14
JM - Giamaica 13
LV - Lettonia 13
PH - Filippine 13
TN - Tunisia 13
NP - Nepal 12
PE - Perù 12
KZ - Kazakistan 11
LB - Libano 11
RO - Romania 11
RS - Serbia 10
UY - Uruguay 10
CR - Costa Rica 9
MY - Malesia 9
PT - Portogallo 9
AL - Albania 8
IL - Israele 8
PS - Palestinian Territory 8
EU - Europa 7
GR - Grecia 7
HN - Honduras 7
PA - Panama 7
AZ - Azerbaigian 6
EE - Estonia 6
HU - Ungheria 5
LY - Libia 5
MK - Macedonia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
DK - Danimarca 4
ET - Etiopia 4
LU - Lussemburgo 4
NI - Nicaragua 4
NO - Norvegia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
CG - Congo 3
CY - Cipro 3
GE - Georgia 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
SY - Repubblica araba siriana 3
TG - Togo 3
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 37.355
Città #
Southend 2.524
Dallas 2.090
Fairfield 1.398
Dublin 1.374
Singapore 1.228
Ashburn 1.131
Moscow 761
Santa Clara 737
Chandler 674
Woodbridge 664
San Jose 619
Beijing 541
Seattle 536
Houston 535
Hong Kong 525
Jacksonville 511
Wilmington 498
Hefei 482
Menlo Park 478
Siena 468
Cambridge 451
Ann Arbor 416
New York 413
Seoul 347
Milan 277
Los Angeles 270
Princeton 258
The Dalles 244
Ho Chi Minh City 227
Hanoi 206
Lauterbourg 194
Munich 180
Johannesburg 176
Nanjing 157
Council Bluffs 147
Helsinki 139
Rome 136
Dong Ket 134
Florence 120
São Paulo 103
San Mateo 100
Dearborn 98
Boardman 94
San Diego 92
Buffalo 85
Izmir 83
Orem 80
Nanchang 69
Shanghai 68
Chicago 63
London 62
Bengaluru 58
Redondo Beach 57
Frankfurt am Main 55
Turku 55
Columbus 54
Málaga 54
Brussels 52
Abuja 51
Warsaw 47
Abidjan 46
Guangzhou 46
Rio de Janeiro 45
Hebei 42
Tokyo 41
Brooklyn 40
Shenyang 40
Toronto 40
Chennai 39
Changsha 37
Da Nang 36
Montreal 36
Kunming 35
San Francisco 35
Düsseldorf 34
Nuremberg 34
Redwood City 34
Washington 34
Jinan 33
Stockholm 32
Tianjin 32
Turin 29
Lappeenranta 28
Phoenix 28
Portsmouth 27
Atlanta 26
Venezia 25
Belo Horizonte 24
Haiphong 24
Palermo 24
Bologna 23
Denver 23
Mexico City 23
Lahore 22
Naples 22
Boston 21
Fremont 21
Mumbai 21
Tashkent 21
Jiaxing 20
Totale 24.989
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 888
CD93 as a potential target in neovascular Age-related Macular Degeneration 399
TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration 395
Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium 362
Corneal complications during and after vitrectomy for retinal detachment in photorefractive keratectomy treated eyes 358
Bifocal refractive corneal inlay implantation to improve near vision in emmetropic presbyopic patients 357
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 348
Complex retinal detachment in phakic patients: previtrectomy. Phacoemulsification Versus Combined Phacovitrectomy 347
Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization 346
HTRA1 and TGF-β1 concentrations in the aqueous humor of patients with neovascular age-related macular degeneration 340
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 330
A case of conjunctival involvement with mycosis fungoides successfully treated by surgery. 328
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 326
An In Vivo Confocal Microscopy Analysis of Effects of Topical Antiglaucoma Therapy With Preservative on Corneal Innervation and Morphology. 322
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 314
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 314
Corneal Subbasal Nerve Density and Sensitivity After Pars Plana Vitrectomy Using Contact or Noncontact Wide-Angle Viewing Systems 310
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 310
Long-term evaluation of corneal sub-basal nerve recovery after photorefractive keratectomy and influence of pars plana vitrectomy 307
The extracellular matrix complexity of idiopathic epiretinal membranes and the bilaminar arrangement of the associated internal limiting membrane in the posterior retina 303
The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration 298
Superior properties of N-acetylcysteine ethyl ester over n-acetyl cysteine to prevent retinal pigment epithelial cells oxidative damage 295
A randomized prospective study comparing trabeculectomy with and without the use of a new removable suture 294
Co-Expression of Podoplanin and CD44 in Proliferative Vitreoretinopathy Epiretinal Membranes 292
Mini-incision cataract surgery and toric lens implantation for the reduction of high myopic astigmatism in patients with pellucid marginal degeneration 290
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 290
Vitreous incarceration in sclerotomies after valved 23-, 25-, or 27-gauge and nonvalved 23- or 25-gauge macular surgery 288
Amniotic membrane graft: histopathological findings in five cases. 284
Response to the letter to the editor entitled "Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization" 280
CD-34 stromal expression pattern in normal and altered human corneas 279
Capsule contraction syndrome with a microincision foldable hydrophilic acrylic intraocular lens: two case reports and review of the literature 277
Amniotic membrane transplantation in ocular surface disorders. 277
Untangling the extracellular matrix of idiopathic epiretinal membrane: a path winding among structure, interactomics and translational medicine 275
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 271
F6H8 as an Intraoperative Tool and F6H8/Silicone Oil as a Postoperative Tamponade in Inferior Retinal Detachment with Inferior PVR 267
The peculiar pattern of type IV collagen deposition in epiretinal membranes 266
The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization 266
A preliminary report on the characterization of epiretinal membranes excised from patients affected by macular pucker 263
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 262
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 259
The Incidence of Rhegmatogenous Retinal Complications in Macular Surgery after Prophylactic Preoperative Laser Retinopexy 258
Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study 255
Impact of intraoperative topical hydroxypropyl methylcellulose 2% versus sodium hyaluronate 1.2% on corneal reepithelialization after intentional epithelial debridement during vitrectomy 253
A study of quiet eye's phenomenon in the shooting section of "laser run" of modern pentathlon 250
Disease pathways in proliferative vitreoretinopathy: an ongoing challenge 248
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 247
Heat shock protein (HSP)90 involvement in the development of idiopathic epiretinal membranes 247
Cd93 signaling via rho proteins drives cytoskeletal remodeling in spreading endothelial cells 247
Vitreous incarceration in sutured vs non-sutured sclerotomies after 25-gauge macular surgery 241
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 240
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 239
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 237
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 233
Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. 233
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 233
Corneal collagen cross-linking to stop corneal ectasia exacerbated by radial keratotomy 232
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 231
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 231
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 230
The Controversial Role of TGF-β in Neovascular Age-Related Macular Degeneration Pathogenesis. 227
Clinical and ultrasound biomicroscopic features in iris melanocytoma. 226
Prophylactic preoperative laser retinopexy does not reduce the occurrence of rhegmatogenous retinal complications in macular surgery 226
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 223
Flap displacement during vitrectomy 24 months after laser in situ keratomileusis 223
Digital surface microscopy analysis of conjunctival pigmented lesions: a preliminary study. 223
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 223
Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses 221
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 219
Molecular modulators of anti-VEGF response in neovascular age-related macular degeneration: aqueous humor dynamics of CD93 and endocannabinoids 218
Unilateral retinitis pigmentosa in a woman and pigmented paravenous chorioretinal atrophy in her daughter and son 218
Treatment of macular edema because of occlusive vasculitis with bevacizumab (avastin): efficacy of three consecutive monthly injections 218
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis 217
In vivo confocal microscopy in recurrent granular dystrophy in corneal graft after penetrating keratoplasty 217
Closed-system and open-sky capsulorhexis for combined cataract extraction and corneal transplantation. 216
Diagnosis and management of traumatic cyclodialysis cleft 216
The C-type lectin CD93 controls endothelial cell migration via activation of the Rho family of small GTPases 216
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 213
IL-6 blockade in the management of non-infectious uveitis 206
Corneal invasion of ocular surface squamous neoplasia after clear corneal phacoemulsification: in vivo confocal microscopy analysis 206
Glare disability and spherical aberration with five foldable intraocular lenses: a prospective randomized study 205
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis 204
Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells 203
Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implication for pathogenesis and therapeutic approach 203
Usher syndrome type 1 associated with primary ciliary aplasia 203
Translationally Controlled Tumour Protein (TCTP) is present in human cornea and increases in herpetic keratitis 203
Iontophoresis corneal cross-linking with enhanced fluence and pulsed UV-A light: 3-year clinical results 203
Cell composition and immunohistochemical detection of VEGF, TGF-ß and TNF-α in proliferative vitreoretinopathy 199
In vivo confocal microscopy in bilateral herpetic keratitis: a case report 198
New molecular targets for the treatment of neovascular age-related macular degeneration 198
In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy 197
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 195
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review 194
Development and implementation of the AIDA International Registry for patients with Behçet's disease 193
Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases 193
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 191
Management of severe hypotony with intravitreal injection of viscoelastic. 191
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 191
LRG1 expression is elevated in the eyes of patients with neovascular age-related macular degeneration 191
Visual field loss progression after macular hole surgery. 190
Optical aberrations in pseudophakic eyes after 2.5-mm Nd:YAG laser capsulotomy for posterior capsule opacification 188
Totale 25.967
Categoria #
all - tutte 110.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021303 0 0 0 0 0 0 0 0 0 0 0 303
2021/20222.353 220 317 182 192 121 55 121 95 122 233 252 443
2022/20232.670 169 236 346 347 231 526 73 206 276 87 92 81
2023/20242.605 82 70 214 132 128 778 773 71 24 78 74 181
2024/20256.039 244 274 506 328 799 397 253 410 517 300 611 1.400
2025/202613.477 996 2.110 1.636 1.678 2.479 514 1.557 447 507 725 502 326
Totale 38.006